MENU

Nanotherapeutics: An insight into healthcare and future multi-dimensional clinical applications

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Research Affiliate, Integrative Behavioural Health Research Institute
    Biography
      Pratibha Kakadia received her PhD in Pharmaceutical Science from University of Huddersfield, England, UK. Her graduate research was completed in the lab of Prof. Barbara Conway, Ph.D. Her research is focussed on the investigation of design and development of nanoformulations for the targeted delivery of antibacterial drugs for treatment of skin infections. She has worked as Scientist in Merck Research Labs in Pennsylvania, supporting formulation of RNA based lipid nanoparticles delivery for preclinical research. Currently, Pratibha is the Research Affiliate with Integrative Behavioural Health Research Institute, Pasadena, California. She has three-first author publications in the reputed peer-reviewed journals and 2 oral and 10 poster talks on the design and formulation of lipid nanoparticles approach for controlled and targeted drug delivery.

    Abstract

    In recent years Nanotherapeutics has revolutionized the healthcare strategies and envisioned to have a tremendous impact to offer better health facilities. It involves design, fabrication, regulation, and application of therapeutic drugs and devices having a size in nano-range (1–100 nm). Owing to the revolutionary implications in drug delivery and gene therapy, lipid nanoparticles has gained increasing research interest in the current medical sector of the modern world. Current clinical efforts are focused on vaccination, protein replacement therapies, and treatment of genetic diseases. Since the first pre-clinical studies in the 1990s, significant progress in the clinical translation of mRNA therapeutics has been made through advances in the design of mRNA manufacturing and intracellular delivery methods. The growth of such powerful biologic therapeutics has gone hand in hand with the progress in delivery systems technology, which is absolutely required to improve their safety and effectiveness.

    One of the most developed methods for RNA delivery is co-formulation into lipid nanoparticles (LNP). LNP as drug delivery vehicles is becoming more attractive because it can pack drug product more efficiently, enhance its bioavailability, and target specific cells. In this presentation, we discuss the revolution of lipid nanoparticles into precision medicine and recent advances in biomaterials and drug delivery strategies, challenges for clinical translations of RNA based therapeutics with an overview of the future clinical applications in protein therapy, gene editing, and vaccination.

    Learning Objectives:

    1. What current Nanomedicine are being developed for drug delivery

    2. Why use lipid nanoparticles for RNA delivery

    3. Recent advances and clinical applications


    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    OCT 08, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    Loading Comments...
    Show Resources